Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide pharmaceuticals for insulin resistance

Peptide pharmaceuticals for insulin resistance

US Patent 10577405 · Granted Mar 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide pharmaceuticals for treatment of NASH and other disorders2025
Peptide pharmaceuticals for insulin resistance2024
Peptide pharmaceuticals for treatment of NASH and other disorders2023
Peptide pharmaceuticals for insulin resistance2021
Peptide pharmaceuticals for insulin resistance2019
Peptide pharmaceuticals2019
Peptide pharmaceuticals2018
Peptide pharmaceuticals2018
Peptide pharmaceuticals for insulin resistance2018
Vasoactive intestinal polypeptide pharmaceuticals2009
Vasoactive intestinal polypeptide pharmaceuticals2009
Compounds and methods for treating insulin resistance and cardiomyopathy2007